Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01181596 · ClinicalTrials.gov registry record
NICU-TECH RM9L-RS Probe ME Feasibility Study
A clinical trial, sponsored by GE Healthcare.
- Terminated
- Registry status
- 31
- Enrollment target
NCT01181596: Clinical Trial study, sponsored by GE Healthcare.
NCT01181596 is a clinical trial that was terminated before completion, run by GE Healthcare. The registered enrollment target is 31 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01181596 was terminated before completion, sponsored by GE Healthcare.
- TERMINATED
- Registry status
- 31 participants
- Enrollment target
Study Summary
Use of a new ultrasound device designed for babies to look at the catheters in veins and arteries as well as the blood vessel itself. An observational study to assess the the clinicians perception of the ultrasound image quality as a tool to detect catheters in vessels.
Primary Outcome
Acquisition of basic images and video were obtained from study participants who already have one or more catheters in place.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2010-06 |
| Est. Completion | 2011-11 |
Why NCT01181596 stopped before completion
NCT01181596 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 31 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01181596 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01181596 about?
NCT01181596 is a clinical study titled "NICU-TECH RM9L-RS Probe ME Feasibility Study". Use of a new ultrasound device designed for babies to look at the catheters in veins and arteries as well as the blood vessel itself. An observational study to assess the the clinicians perception of the ultrasound image quality as a tool to detect catheters in vessels.
What is the current status of trial NCT01181596?
This trial is currently terminated. The enrollment target is 31 participants. The study started on 2010-06. Estimated completion is 2011-11.
Who is sponsoring clinical trial NCT01181596?
This trial is sponsored by GE Healthcare, which has 99 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia